Type 1 Diabetes Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2018–2024

Request Brochure Request Discount

Report Code: ZMR-2920 | Report Format : | Status : Upcoming |

Abstract

Global Type 1 Diabetes Market: Overview

Type 1 Diabetes or previously known as ‘Juvenile Diabetes’ or Diabetes Mellitus. Type 1 is a multifactorial chronic and autoimmune condition during which the body produces little or no insulin in the pancreas. Insulin hormone is needed by the body to get glucose from the bloodstream into the cells to produce energy. Most of the diabetes cases can be classified as type 1a – Autoimmune disease, where the destruction of pancreatic beta cells is observed, low production of insulin disrupts blood glucose homeostasis and minor cases of type 1b – Idiopathic Diabetes Mellitus. This type of diabetes is rare and develops during childhood or adolescence, but can also be seen in adults. Frequent urination, excessive thirst, increased hunger, weight loss, and fatigue are some of the typical symptoms. Diabetes diagnostic devices encompass test strips, lancets, analog blood meter along with insulin delivery devices such as insulin syringe, insulin pump, insulin pen and insulin jet injectors.

Global Type 1 Diabetes Market: Growth Factors

The global type 1 diabetes market is expected to bolster at a significant growth rate over the forecast period owing to the decisive use of insulin for treatment of the disease along with increasing use of insulin delivery apparatus. Unhealthy food habits, rising obesity rates, and sedentary lifestyle are key contributing factors fueling the growth of global type 1 diabetes market. Government initiatives for diabetes control, the economic impact of the disease on the healthcare systems of several countries calls for growth of the market. Whereas, hostile reimbursement policies and high costs of diagnosis and treatment are restraining factors for the growth of global type 1 diabetes market. The innovation of newer molecules from newer class of diabetic drugs along with a strong pipeline would be an opportunity for growth along with an extension in development of non-invasive diabetes diagnostics and drug delivery devices can also be seen as an opportunity. Considering the side effects associated with the treatment therapies of type 1 diabetes could be seen as a challenge for the growth of the market.

Global Type 1 Diabetes Market: Segmentation

Global type 1 diabetes market is segmented on the basis of insulin analog as rapid-acting insulin analogs, long-acting insulin analogs, and premix insulin analogs. Rapid-acting insulin segment is again classified as Aspart, Glulisine, and Lyspro. Rapid action segment is anticipated to expand at a significant growth rate over the forecast period attributed to increased uptake of the novel formulations. Premix insulin analogs own the properties of both rapid and long-acting insulin and have ratios of long-acting insulin and rapid-acting insulin.

Global Type 1 Diabetes Market: Regional Analysis

Based on geography global honey market is segmented into five major segments including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Among the aforementioned regions, type 1 diabetes market is dominated by North America owing to increasing cases of diabetes in the region. The U.S. is emerging as the power market with a significant number of children below fourteen years who have type 1 diabetes compared to other countries in the region. Asia-Pacific is expected to record the substantial growth rate during the forecast period attributed to rise in the aging population in the region, with India emerging as the potential leader for the market within a forecast period.

Global Type 1 Diabetes Market: Competitive Players

Some of the key players included in type 1 diabetes market are Eli Lilly and Company, Bayer Pharmaceuticals, Sanofi, Novo Nordisk, AstraZeneca PLC., XOMA Corp., DiaVacs Inc., B.BraunMelsungen AG, Biodel Inc., Macrogenics Inc., and Takeda Pharmaceutical.

Global Type 1 Diabetes Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • The UK
    • France
    • Germany
  • The Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Pharmaceutical Excipients Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2024

Price : $ 3599.00 | Report Code: ZMR-2947 | Report Format:

Global Pharmaceutical Excipients Market: Overview An inactive substance, acting as a carrier with no medicinal properties that play a role in aiding characteristics which help in the formation of a tablet is known as excipients. It basically involves all the substance (except active pharmaceutic...Read More

Bipolar Disorder Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2940 | Report Format:

Global Bipolar Disorder Market: Overview Bipolar disorder is usually recognized as manic depression, it is a kind of mental illness which is mainly categorized by mood swings. Mood episodes are basically of two types: depressive and manic episodes. The changes or transformation in the mental con...Read More

Breakthrough Therapy (BT) Designation Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2939 | Report Format:

Global Breakthrough Therapy (BT) Designation Market: Overview The breakthrough designation therapy is granted to medicines/drugs that bring about considerable betterment in syndrome conditions as compared to existing therapies at the time of preliminary stages of medical trials for the healing o...Read More

Hemophilia Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3999.00 | Report Code: ZMR-2935 | Report Format:

Global Hemophilia Market: Overview Hemophilia is basically genetic bleeding syndrome caused owing to shortage or missing protein required for clotting, owing to which blood clotting does not take place. The episodes of bleeding majorly depend on the severity of hemophilia issue. There are two ma...Read More

Intravenous Immunoglobulin (IVIG) Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3999.00 | Report Code: ZMR-2934 | Report Format:

Global Intravenous Immunoglobulin (IVIG) Market: Overview Immunoglobulins (IGs) are basically glycoproteins generated in the blood plasma in reaction to the antigens, which are entirely foreign to the host system. They are extremely complex entities as well as explicit in their action. They are ...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.